AbCellera Biologics Inc. is a leading biotechnology company specializing in the discovery of monoclonal antibodies. Using their proprietary technology, they are revolutionizing the field of drug discovery by rapidly identifying and developing potential therapeutic candidates for a range of diseases. With numerous partnerships and a robust pipeline, AbCellera is at the forefront of innovation in the biopharmaceutical industry.
